The COVID-19 Long Haul Foundation

Treatment, Referral & Educational Support for COVID-19 Illnesses & Vaccine Injury

FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots

By  LAURAN NEERGAARD and MATTHEW PERRONE WASHINGTON (AP) — The Trump administration’s effort to impose new requirements on Novavax’s COVID-19 vaccine — the nation’s only traditional protein-based option for the coronavirus — is sowing uncertainty about updates to other […]

Outcomes of Hip Avascular Necrosis Following COVID-19 Infection

Adarsh Annapareddy • Praharsha Mulpur • Tarun Jayakumar • et. al., DOI: 10.7759/cureus.87230  Abstract Introduction: Avascular necrosis (AVN) of the femoral head has been observed to occur after COVID-19, especially if steroids were taken. However, the knowledge […]

Idiopathic Retroperitoneal Hematoma Associated With Anticoagulation in a Patient With Moderate COVID-19 Pneumonia

Hikaru Murooka • Natsumi Yamamoto • Shiho Amano •, et. al. DOI: 10.7759/cureus.87395  Abstract We report a case of idiopathic retroperitoneal hematoma in an 82-year-old man with moderate COVID-19 pneumonia receiving prophylactic anticoagulation therapy. The patient […]

FDA vaccine official restricted COVID vaccine approvals against the advice of agency staff

By  MATTHEW PERRONE WASHINGTON (AP) — The government’s top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval of two COVID-19 vaccines, disregarding recommendations from government scientists, according to federal documents released […]

BOMBSHELL Study: COVID Shots Cripple Immune System — Possibly Permanently

Benjamin Bartee  While many in corporate state media*, and even independent media, were at some point agnostic or even enthusiastic about the fruits of Operation Warp Speed, I am proud […]

Intranasal Chlorpheniramine for Early Symptomatic Treatment of COVID-19 and the Impact on Long-COVID

Gustavo Ferrer • Fernando Valerio-Pascua • César Alas-Pineda • et.al., DOI: 10.7759/cureus.82736  Abstract This review explores the therapeutic potential of intranasal chlorpheniramine maleate (iCPM) in managing both acute COVID-19 and Long COVID by integrating histamine H1 receptor […]